Bios Equity COF LP insider trades
Open-market stock purchases and sales by Bios Equity COF LP, Director, 10% Owner at Actuate Therapeutics, Inc, from SEC Form 4 filings since Aug 12, 2024.
Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -76%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- ACTU Actuate Therapeutics, Inc: 3 buys, 6 sales, last Jun 27, 2025